These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33892696)

  • 1. Development and internal validation of a prediction model of prostate cancer on initial transperineal template-guided prostate biopsy.
    Chen Y; Zhou Z; Zhou Y; Wu X; Xiao Y; Ji Z; Li H; Yan W
    BMC Urol; 2021 Apr; 21(1):68. PubMed ID: 33892696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and external multicenter validation of Chinese Prostate Cancer Consortium prostate cancer risk calculator for initial prostate biopsy.
    Chen R; Xie L; Xue W; Ye Z; Ma L; Gao X; Ren S; Wang F; Zhao L; Xu C; Sun Y;
    Urol Oncol; 2016 Sep; 34(9):416.e1-7. PubMed ID: 27185342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Efficacy of Transrectal Ultrasound Guided Biopsy Versus Transperineal Template Biopsy of the Prostate in Diagnosing Prostate Cancer in Men with Previous Negative Transrectal Ultrasound Guided Biopsy.
    Nafie S; Wanis M; Khan M
    Urol J; 2017 Mar; 14(2):3008-3012. PubMed ID: 28299763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy.
    Lee CU; Sung SH; Jang CT; Kang M; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
    Urol Int; 2019; 103(3):262-269. PubMed ID: 31269509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
    Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
    Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
    Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
    J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward an MRI-based nomogram for the prediction of transperineal prostate biopsy outcome: A physician and patient decision tool.
    Lee SM; Liyanage SH; Wulaningsih W; Wolfe K; Carr T; Younis C; Van Hemelrijck M; Popert R; Acher P
    Urol Oncol; 2017 Nov; 35(11):664.e11-664.e18. PubMed ID: 28801025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort.
    Gayet M; Mannaerts CK; Nieboer D; Beerlage HP; Wijkstra H; Mulders PFA; Roobol MJ
    Eur Urol Focus; 2018 Mar; 4(2):228-234. PubMed ID: 28753781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active Surveillance.
    Dieffenbacher S; Nyarangi-Dix J; Giganti F; Bonekamp D; Kesch C; Müller-Wolf MB; Schütz V; Gasch C; Hatiboglu G; Hauffe M; Stenzinger A; Duensing S; Schlemmer HP; Moore CM; Hohenfellner M; Radtke JP
    Eur Urol Focus; 2021 Jan; 7(1):102-110. PubMed ID: 30878348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy.
    Song W; Kang M; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
    Investig Clin Urol; 2019 Nov; 60(6):454-462. PubMed ID: 31692988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a nomogram combining multiparametric magnetic resonance imaging and PSA-related parameters to enhance the detection of clinically significant cancer across different region.
    Zhou Z; Liang Z; Zuo Y; Zhou Y; Yan W; Wu X; Ji Z; Li H; Hu M; Ma L
    Prostate; 2022 Apr; 82(5):556-565. PubMed ID: 35098557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy.
    Nowroozi MR; Amini S; Kasaeian A; Zavarehei MJ; Eshraghian MR; Ayati M
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e289-97. PubMed ID: 24684767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and validation of serum lipid-based nomogram for predicting the risk of prostate cancer.
    Feng F; Zhong YX; Chen Y; Lin FX; Huang JH; Mai Y; Zhao PP; Wei W; Zhu HC; Xu ZP
    BMC Urol; 2023 Jul; 23(1):120. PubMed ID: 37452418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Preliminary Study of the Ability of the 4Kscore test, the Prostate Cancer Prevention Trial-Risk Calculator and the European Research Screening Prostate-Risk Calculator for Predicting High-Grade Prostate Cancer.
    Borque-Fernando Á; Esteban-Escaño LM; Rubio-Briones J; Lou-Mercadé AC; García-Ruiz R; Tejero-Sánchez A; Muñoz-Rivero MV; Cabañuz-Plo T; Alfaro-Torres J; Marquina-Ibáñez IM; Hakim-Alonso S; Mejía-Urbáez E; Gil-Fabra J; Gil-Martínez P; Ávarez-Alegret R; Sanz G; Gil-Sanz MJ
    Actas Urol Esp; 2016 Apr; 40(3):155-63. PubMed ID: 26598800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of transperineal template-guided mapping biopsy of the prostate after negative magnetic resonance imaging-guided transrectal biopsy.
    Sivaraman A; Sanchez-Salas R; Ahmed HU; Barret E; Cathala N; Mombet A; Uriburu Pizarro F; Carneiro A; Doizi S; Galiano M; Rozet F; Prapotnich D; Cathelineau X
    Urol Oncol; 2015 Jul; 33(7):329.e7-11. PubMed ID: 25957713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant?
    Doan P; Graham P; Lahoud J; Remmers S; Roobol MJ; Kim L; Patel MI
    BJU Int; 2021 Dec; 128 Suppl 3():36-44. PubMed ID: 34374190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators.
    Roobol MJ; van Vugt HA; Loeb S; Zhu X; Bul M; Bangma CH; van Leenders AG; Steyerberg EW; Schröder FH
    Eur Urol; 2012 Mar; 61(3):577-83. PubMed ID: 22104592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy.
    Park SJ; Miyake H; Hara I; Eto H
    Int J Urol; 2003 Feb; 10(2):68-71. PubMed ID: 12588600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of a PCA-3-based nomogram for predicting prostate cancer and high-grade cancer on initial prostate biopsy.
    Greene DJ; Elshafei A; Nyame YA; Kara O; Malkoc E; Gao T; Jones JS
    Prostate; 2016 Aug; 76(11):1019-23. PubMed ID: 27197726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.